New research shows that the anti-anxiety and hallucinogenic-like effects of a psychedelic drug work through different neural circuits. The study, in a mouse model, shows that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics.

UC Davis researchers unveil CaST, a tool that rapidly tags neurons affected by psychedelics, offering insights into therapeutic mechanisms.